Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML

MeSH terms

• Clinical Decision-Making
• Disease Management
• High-Throughput Nucleotide Sequencing
• Humans
• Isocitrate Dehydrogenase / genetics*
• Leukemia, Myeloid, Acute / diagnosis*
• Leukemia, Myeloid, Acute / genetics*
• Leukemia, Myeloid, Acute / therapy
• Mutation*
• Neoplasm, Residual / diagnosis*
• Neoplasm, Residual / genetics*
• Prognosis